N. Aslam et al., Prospective evaluation of three different models for the pre-operative diagnosis of ovarian cancer, BR J OBST G, 107(11), 2000, pp. 1347-1353
Objective To test the accuracy of the risk of malignancy index, the revised
risk of malignancy index and Tailor's regression model to diagnose maligna
ncy in women with known adnexal masses.
Design Prospective collaborative study.
Setting Gynaccology Assessment Unit, Department of Obstetrics and Gynaecolo
gy, King's College Hospital, London.
Sample Sixty-one women with known adnexal masses were examined pre-operativ
ely. Women were recruited from three South London hospitals.
Methods The demographic, biochemical and sonographic data recorded for each
patient included: age; menopausal status; CA125 levels; tumour volume; ult
rasound characteristics; and Doppler blood flow analysis (peak and mean blo
od velocities, the pulsatility and resistance indices). The diagnosis of ma
lignancy was made for each woman using all three models and the results com
pared with the final histopathological diagnosis.
Results Thirty-eight women had benign rumours and 23 had ovarian cancer. Wo
men with malignant tumours were significantly older than those with benign
masses. There were also significant differences in CA125 levels, locularity
, presence of papillary proliferations and ascites between the two groups.
Tailor's regression model achieved a 43% sensitivity and 92% specificity in
the diagnosis of malignancy. This compared with a 74% sensitivity and 92%
specificity with the risk of malignancy model, and a 74% sensitivity and 89
% specificity with the revised risk of malignancy model.
Conclusion When applied prospectively all three diagnostic models performed
less accurately than originally reported, despite clinical signs of malign
ancy being present in many cases. It is likely that their accuracy would be
even less in a population of women in whom there was a substantial clinica
l uncertainty. Intra-tumoral blood velocity and CA125 levels were the best
individual parameters for discrimination between benign and malignant tumou
rs.